Cathie Wood’s ARK Invest made more than $10 million in trades on March 12, 2026, according to the firm’s daily disclosures.

Lipid nanoparticles, or LNPs, are best known as the delivery system used in the COVID-19 mRNA vaccines given to billions of people worldwide. Scientists are now exploring their potential far beyond ...

Advances in gene editing tools like CRISPR‑Cas9 and pre-implantation embryo screening are turning the idea of designer babies — selecting or altering embryonic traits — into a possibility rather than ...

ARK Invest deployed over $10M in CRISPR Therapeutics and PayPay Corp on March 12, while cutting positions in Teradyne and Ionis Pharmaceuticals.

UK agbiotech Tropic raises $105m to scale gene-edited non-browning and extended shelf-life bananas, and advance TR4-resistant varieties.

"2025 proved that our technology delivers, not in the distant future, but right now," says Tropic CEO Gilad Gershon.

Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution.

Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:30 AM EDTCompany ParticipantsAmy Parison - Senior VP ...

Explore the future of gene therapy delivery with lipid nanoparticles. Learn how they can transform treatments for various diseases.

Scientists at the Wisconsin Crop Innovation Center are pioneering the future of hemp farming. Researchers at UW-Madison have received deregulation from the U.S. Department of Agriculture for ...

Lipid nanoparticles (LNPs) act as carriers for mRNA and CRISPR payloads across a wide range of therapeutic applications, from cancer to inflammatory and genetic diseases. The same delivery system used ...

The Garden Club of Palm Beach and The Society of the Four Arts will host a presentation by Cold Spring Harbor Laboratory professor Zachary Lippman at the Dixon Education Building March 19. During his ...